0001127602-21-023108.txt : 20210804
0001127602-21-023108.hdr.sgml : 20210804
20210804182806
ACCESSION NUMBER: 0001127602-21-023108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210802
FILED AS OF DATE: 20210804
DATE AS OF CHANGE: 20210804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wall Brett A.
CENTRAL INDEX KEY: 0001473812
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36820
FILM NUMBER: 211145578
MAIL ADDRESS:
STREET 1: 710 MEDTRONIC PARKWAY
STREET 2: LC300
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medtronic plc
CENTRAL INDEX KEY: 0001613103
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 01135314381700
MAIL ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Ltd
DATE OF NAME CHANGE: 20150112
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Holdings Ltd
DATE OF NAME CHANGE: 20140711
FORMER COMPANY:
FORMER CONFORMED NAME: Kalani I Ltd
DATE OF NAME CHANGE: 20140709
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-08-02
0001613103
Medtronic plc
MDT
0001473812
Wall Brett A.
710 MEDTRONIC PARKWAY
LC300
MINNEAPOLIS
MN
55432
1
EVP & Pres Neuroscience
Ordinary Shares
2021-08-02
4
F
0
1482
131.31
D
20062
D
Ordinary Shares
2021-08-02
4
A
0
5333
0
A
25395
D
Stock Option (Right to Buy)
131.26
2021-08-02
4
A
0
45565
0
A
2022-08-02
2031-08-02
Ordinary Shares
45565
45565
D
Stock Option (Right to Buy)
131.26
2021-08-02
4
A
0
1085
0
A
2022-08-02
2031-08-02
Ordinary Shares
1085
1085
D
Performance Share Units
2021-08-02
4
A
0
13333
0
A
Performance Share Units
13333
13333
D
This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment.
This balance increased by 83 shares due to exempt transactions such as dividend reinvestment.
The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 13,333 shares will be issued. The actual number of shares to be issued could range from a low of 2,667 shares at minimum performance to a high of 26,666 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
Vests on August 2, 2024.
/s/ Thomas L. Osteraas, attorney-in-fact
2021-08-04